Target Price | CHF4,186.38 |
Price | CHF4,124.00 |
Potential | 1.51% |
Number of Estimates | 21 |
21 Analysts have issued a price target Givaudan 2026 . The average Givaudan target price is CHF4,186.38. This is 1.51% higher than the current stock price. The highest price target is CHF4,900.00 18.82% , the lowest is CHF3,500.00 15.13% . | |
A rating was issued by 23 analysts: 9 Analysts recommend Givaudan to buy, 9 to hold and 5 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Givaudan stock has an average upside potential 2026 of 1.51% . Most analysts recommend the Givaudan stock at Buy or hold. |
20 Analysts have issued a sales forecast Givaudan 2025 . The average Givaudan sales estimate is CHF7.7b . This is 3.47% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF7.8b 5.69% , the lowest is CHF7.5b 1.38% .
This results in the following potential growth metrics:
2024 | CHF7.4b | 7.19% |
---|---|---|
2025 | CHF7.7b | 3.47% |
2026 | CHF8.0b | 4.42% |
2027 | CHF8.4b | 5.18% |
2028 | CHF9.0b | 7.03% |
2029 | CHF9.7b | 7.73% |
19 Analysts have issued an Givaudan EBITDA forecast 2025. The average Givaudan EBITDA estimate is CHF1.9b . This is 21.03% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF1.9b 25.44% , the lowest is CHF1.8b 15.61% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF1.5b | 23.35% |
---|---|---|
2025 | CHF1.9b | 21.03% |
2026 | CHF1.9b | 4.49% |
2027 | CHF2.0b | 5.28% |
2028 | CHF2.1b | 3.97% |
2029 | CHF2.2b | 2.39% |
2024 | 20.74% | 15.08% |
---|---|---|
2025 | 24.26% | 16.99% |
2026 | 24.27% | 0.04% |
2027 | 24.29% | 0.08% |
2028 | 23.60% | 2.84% |
2029 | 22.43% | 4.96% |
14 Givaudan Analysts have issued a net profit forecast 2025. The average Givaudan net profit estimate is CHF1.1b . This is 4.30% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.2b 9.47% , the lowest is CHF1.1b 1.76% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF1.1b | 22.06% |
---|---|---|
2025 | CHF1.1b | 4.30% |
2026 | CHF1.2b | 8.19% |
2027 | CHF1.3b | 7.60% |
2028 | CHF1.4b | 3.81% |
2029 | CHF1.4b | 1.35% |
2024 | 14.71% | 13.88% |
---|---|---|
2025 | 14.82% | 0.78% |
2026 | 15.36% | 3.64% |
2027 | 15.71% | 2.28% |
2028 | 15.24% | 2.99% |
2029 | 14.34% | 5.91% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 117.63 | 123.17 |
21.93% | 4.71% | |
P/E | 33.48 | |
EV/Sales | 5.54 |
14 Analysts have issued a Givaudan forecast for earnings per share. The average Givaudan EPS is CHF123.17 . This is 4.79% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF129.28 9.99% , the lowest is CHF116.02 1.29% .
This results in the following potential growth metrics and future valuations:
2024 | CHF117.63 | 21.93% |
---|---|---|
2025 | CHF123.17 | 4.71% |
2026 | CHF133.26 | 8.19% |
2027 | CHF143.39 | 7.60% |
2028 | CHF148.85 | 3.81% |
2029 | CHF150.87 | 1.36% |
Current | 35.09 | 21.57% |
---|---|---|
2025 | 33.48 | 4.58% |
2026 | 30.95 | 7.56% |
2027 | 28.76 | 7.08% |
2028 | 27.71 | 3.65% |
2029 | 27.34 | 1.34% |
Based on analysts' sales estimates for 2025, the Givaudan stock is valued at an EV/Sales of 5.54 and an P/S ratio of 5.02 .
This results in the following potential growth metrics and future valuations:
Current | 5.73 | 10.19% |
---|---|---|
2025 | 5.54 | 3.33% |
2026 | 5.30 | 4.24% |
2027 | 5.04 | 4.93% |
2028 | 4.71 | 6.57% |
2029 | 4.37 | 7.18% |
Current | 5.19 | 9.85% |
---|---|---|
2025 | 5.02 | 3.35% |
2026 | 4.81 | 4.23% |
2027 | 4.57 | 4.93% |
2028 | 4.27 | 6.57% |
2029 | 3.96 | 7.17% |
Analyst | Rating | Action | Date |
---|---|---|---|
RESEARCH PARTNERS AG |
Buy
➜
Buy
|
Unchanged | Apr 02 2025 |
BERENBERG |
Hold
➜
Buy
|
Upgrade | Mar 31 2025 |
ESN/CIC MARKET SOLUTIONS |
Neutral
➜
Neutral
|
Unchanged | Mar 30 2025 |
BAADER HELVEA EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Mar 25 2025 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Mar 20 2025 |
JEFFERIES |
Underperform
➜
Underperform
|
Unchanged | Mar 12 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RESEARCH PARTNERS AG:
Buy
➜
Buy
|
Apr 02 2025 |
Upgrade
BERENBERG:
Hold
➜
Buy
|
Mar 31 2025 |
Unchanged
ESN/CIC MARKET SOLUTIONS:
Neutral
➜
Neutral
|
Mar 30 2025 |
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
➜
Buy
|
Mar 25 2025 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Mar 21 2025 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Mar 20 2025 |
Unchanged
JEFFERIES:
Underperform
➜
Underperform
|
Mar 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.